Shibl A M
King Saud University, Riyadh, Saudi Arabia.
J Int Med Res. 2005 May-Jun;33(3):349-55. doi: 10.1177/147323000503300310.
In the study we characterized the macrolide sensitivity of recent clinical isolates of Streptococcus pyogenes and S. pneumoniae collected from major Saudi Arabian hospitals. Susceptibility testing was performed using standard National Committee for Clinical Laboratory Standards methodology on 335 S. pyogenes and 350 S. pneumoniae isolates. Macrolide resistance mechanism phenotypes were identified using double-disk diffusion. All S. pyogenes were penicillin sensitive, while 6.3% were macrolide resistant, the main mechanism of which was of M phenotype (96%). Approximately 51% of S. pneumoniae were penicillin non-susceptible. Macrolide resistance in S. pneumoniae accounted for 18.8%, the majority of which were M phenotype (91%). Low-level resistance mediated by mef-bearing strains pre-dominated. Newer macrolides, including azithromycin, are still considered drugs of choice for empirical treatment of respiratory infection in such circumstances.
在这项研究中,我们对从沙特阿拉伯主要医院收集的化脓性链球菌和肺炎链球菌近期临床分离株的大环内酯敏感性进行了表征。使用标准的美国国家临床实验室标准委员会方法对335株化脓性链球菌和350株肺炎链球菌分离株进行了药敏试验。使用双碟扩散法鉴定大环内酯耐药机制表型。所有化脓性链球菌对青霉素敏感,而6.3%对大环内酯耐药,其主要机制为M表型(96%)。约51%的肺炎链球菌对青霉素不敏感。肺炎链球菌中的大环内酯耐药率为18.8%,其中大多数为M表型(91%)。携带mef的菌株介导的低水平耐药占主导。包括阿奇霉素在内的新型大环内酯类药物在此类情况下仍被视为呼吸道感染经验性治疗的首选药物。